1. Home
  2. FNWB vs ZTEK Comparison

FNWB vs ZTEK Comparison

Compare FNWB & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$8.99

Market Cap

79.8M

Sector

Finance

ML Signal

N/A

Logo Zentek Ltd.

ZTEK

Zentek Ltd.

N/A

Current Price

$0.55

Market Cap

68.8M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
ZTEK
Founded
1923
2008
Country
United States
Canada
Employees
N/A
N/A
Industry
Banks
Major Chemicals
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
79.8M
68.8M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
FNWB
ZTEK
Price
$8.99
$0.55
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
34.5K
66.6K
Earning Date
04-23-2026
02-18-2026
Dividend Yield
0.80%
N/A
EPS Growth
36.00
N/A
EPS
N/A
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$0.50
52 Week High
$10.98
$1.84

Technical Indicators

Market Signals
Indicator
FNWB
ZTEK
Relative Strength Index (RSI) 47.64 38.71
Support Level $7.56 $0.55
Resistance Level $9.00 $0.75
Average True Range (ATR) 0.29 0.04
MACD 0.05 -0.01
Stochastic Oscillator 67.28 33.33

Price Performance

Historical Comparison
FNWB
ZTEK

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About ZTEK Zentek Ltd.

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Share on Social Networks: